AbelZeta Pharma, AstraZeneca to co-develop a novel GPC3 armored CAR-T therapy in China
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
GMM Pfaudler US completes acquisition of MixPro
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare
Subscribe To Our Newsletter & Stay Updated